b'Appendices Appendix 4 GENOME CANADA Statement of Financial Position March 31, 2019, with comparative information for 2018 (in thousands of dollars)20192018AssetsCurrent assets: Cash$10,672$1,234 Short-term investments (note 3) 30,99638,275 Interest receivable1282 Other receivables76218 Prepaid expenses244170 42,00039,979Capital assets (note 4)3946$42,039$40,025Liabilities and Net AssetsCurrent liabilities: Accounts payable and accrued liabilities (note 5)$782$824 Deferred contributions - research projects (note 6(a))40,09139,155 40,87339,979Deferred lease inducements (note 7) 177Deferred contributions (note 6) Deferred contributions - internally restricted950 Deferred contributions related to capital assets3946 98946Commitments (note 10) Contingencies (note 11)$42,039$40,025 See accompanying notes to financial statements.On behalf of the Board: DirectorDirector44'